Lipoprotein(a) associated risk of atherosclerotic cardiovascular disease is independent of C-reactive protein

被引：0
|
作者：
Thomas, Peter Engel
Vedel-Krogh, Signe
Afzal, Shoaib
Nordestgaard, Borge
Kamstrup, Pia
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4122948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4122948
引用
收藏
页数：2
相关论文
共 50 条
  • [31] C-reactive protein is a mediator of cardiovascular disease
    Bisoendial, Radjesh J.
    Boekholdt, S. Matthijs
    Vergeer, Menno
    Stroes, Erik S. G.
    Kastelein, John J. P.
    EUROPEAN HEART JOURNAL, 2010, 31 (17) : 2087 - U1505
  • [32] C-reactive protein is a bystander of cardiovascular disease
    Anand, Sonia S.
    Yusuf, Salim
    EUROPEAN HEART JOURNAL, 2010, 31 (17) : 2092 - U25
  • [33] C-reactive protein in the prediction of cardiovascular disease
    Horowitz, GL
    Beckwith, BA
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07): : 512 - 513
  • [34] C-reactive protein measurement and cardiovascular disease
    Wald, David S.
    Bestwick, Jonathan P.
    LANCET, 2010, 375 (9720): : 1077 - 1077
  • [35] C-reactive protein screening for cardiovascular disease
    Wiesbauer, F
    Miles, JS
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (02) : 242 - 242
  • [36] EFFECTS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN ON LIPOPROTEIN(A)-ASSOCIATED CARDIOVASCULAR MORTALITY RISK IN PATIENTS WITH CORONARY ARTERY DISEASE UNDERGOING PCI
    Yuan Deshan
    Wang Peizhi
    Yuan Jinqing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 956 - 956
  • [37] Association of C-reactive protein with markers of prevalent atherosclerotic disease
    Folsom, AR
    Pankow, JS
    Tracy, RP
    Arnett, DK
    Peacock, JM
    Hong, YL
    Djoussé, L
    Eckfeldt, JH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (02): : 112 - 117
  • [38] Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM
    Anthonia O Ogbera
    Alfred O Azenabor
    Diabetology & Metabolic Syndrome, 2
  • [39] Comparability of C-reactive protein and highs-sensitive C-reactive protein for cardiovascular risk prediction
    Han, E.
    Fritzer-Szekeres, M.
    Gyongyosi, M.
    Bergler-Klein, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S231 - S232
  • [40] Lipoprotein associated phospholipase A2 and C-reactive protein as predictors of metabolic syndrome in subjects without cardiovascular disease
    Acevedo, M.
    Varleta, P.
    Kramer, V.
    Quiroga, T.
    Prieto, C.
    Parada, J.
    Navarrete, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 140 - 140
12345